Next Article in Journal
Australians are not Meeting the Recommended Intakes for Omega-3 Long Chain Polyunsaturated Fatty Acids: Results of an Analysis from the 2011–2012 National Nutrition and Physical Activity Survey
Next Article in Special Issue
Associations between Vitamin B-12 Status and Oxidative Stress and Inflammation in Diabetic Vegetarians and Omnivores
Previous Article in Journal
A Comprehensive Analysis of Body Mass Index Effect on in Vitro Fertilization Outcomes
Previous Article in Special Issue
Allomyrina Dichotoma Larvae Regulate Food Intake and Body Weight in High Fat Diet-Induced Obese Mice Through mTOR and Mapk Signaling Pathways
Open AccessArticle

Nigerian Honey Ameliorates Hyperglycemia and Dyslipidemia in Alloxan-Induced Diabetic Rats

1
Department of Pharmacology and Therapeutics, Faculty of Medicine, Ebonyi State University, Abakaliki 480214, Ebonyi State, Nigeria
2
Department of Pediatrics, Faculty of Medicine, Ebonyi State University, Abakaliki 480214, Ebonyi State, Nigeria
3
Department of Internal Medicine, Faculty of Medicine, Ebonyi State University, Abakaliki 480214, Ebonyi State, Nigeria
4
Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria, Enugu 400211, Enugu State, Nigeria
5
Department of Physiology, College of Health Sciences, Usmanu Danfodiyo University, Sokoto 840212, Sokoto State, Nigeria
6
Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia
*
Author to whom correspondence should be addressed.
Nutrients 2016, 8(3), 95; https://doi.org/10.3390/nu8030095
Received: 20 November 2015 / Revised: 14 December 2015 / Accepted: 31 December 2015 / Published: 24 February 2016
(This article belongs to the Special Issue Diet and Metabolic Dysfunction)
Diabetic dyslipidemia contributes to an increased risk of cardiovascular disease. Hence, its treatment is necessary to reduce cardiovascular events. Honey reduces hyperglycemia and dyslipidemia. The reproducibility of these beneficial effects and their generalization to honey samples of other geographical parts of the world remain controversial. Currently, data are limited and findings are inconclusive especially with evidence showing honey increased glycosylated hemoglobin in diabetic patients. It was hypothesized that this deteriorating effect might be due to administered high doses. This study investigated if Nigerian honey could ameliorate hyperglycemia and hyperlipidemia. It also evaluated if high doses of honey could worsen glucose and lipid abnormalities. Honey (1.0, 2.0 or 3.0 g/kg) was administered to diabetic rats for three weeks. Honey (1.0 or 2.0 g/kg) significantly (p < 0.05) increased high density lipoprotein (HDL) cholesterol while it significantly (p < 0.05) reduced hyperglycemia, triglycerides (TGs), very low density lipoprotein (VLDL) cholesterol, non-HDL cholesterol, coronary risk index (CRI) and cardiovascular risk index (CVRI). In contrast, honey (3.0 g/kg) significantly (p < 0.05) reduced TGs and VLDL cholesterol. This study confirms the reproducibility of glucose lowering and hypolipidemic effects of honey using Nigerian honey. However, none of the doses deteriorated hyperglycemia and dyslipidemia. View Full-Text
Keywords: honey; diabetes mellitus; hyperglycemia; hyperlipidemia; dyslipidemia; lipid profile; alloxan; rats honey; diabetes mellitus; hyperglycemia; hyperlipidemia; dyslipidemia; lipid profile; alloxan; rats
Show Figures

Figure 1

MDPI and ACS Style

Erejuwa, O.O.; Nwobodo, N.N.; Akpan, J.L.; Okorie, U.A.; Ezeonu, C.T.; Ezeokpo, B.C.; Nwadike, K.I.; Erhiano, E.; Abdul Wahab, M.S.; Sulaiman, S.A. Nigerian Honey Ameliorates Hyperglycemia and Dyslipidemia in Alloxan-Induced Diabetic Rats. Nutrients 2016, 8, 95.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop